Funded Tech Companies

Carmenta Bioscience

Carmenta Bioscience, operating out of Palo Alto, was acquired by Progenity.

Company Overview

Company Name
Carmenta Bioscience
Company Status
Acquired or Merged
Total Funding

Contact Information

Mailing Address
4240 Wilkie Way
Palo Alto, CA 94306
USA
Email Address

Company Background Information

Overview
Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Profile
Carmenta Bioscience LinkedIn Company Profile
Social Media
Carmenta Bioscience Company Twitter Account
Company News
Carmenta Bioscience News
Facebook
Carmenta Bioscience on Facebook
YouTube
Carmenta Bioscience on YouTube
Last Transaction
4/30/2015

Financing History

Date
Type
Amount
M&A
Unknown
Venture Equity
$2,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Cooper
  Matthew Cooper LinkedIn Profile  Matthew Cooper Twitter Account  Matthew Cooper News  Matthew Cooper on Facebook
Chief Scientific Officer
Atul Butte
  Atul Butte LinkedIn Profile  Atul Butte Twitter Account  Atul Butte News  Atul Butte on Facebook
Co-Founder
Bruce Ling
  Bruce Ling LinkedIn Profile  Bruce Ling Twitter Account  Bruce Ling News  Bruce Ling on Facebook


Company Investors

  • Private Investors (Camille Samuels)

 

 

 

Browse more funded tech companies:

Carmelo Systems | Carmera

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary